Literature DB >> 18806572

Inducing resectability of chemotherapy refractory colorectal liver metastasis by radioembolization with yttrium-90 microspheres.

Marc Van den Eynde1, Patrick Flamen, Issam El Nakadi, Gabriel Liberale, Philippe Delatte, Denis Larsimont, Alain Hendlisz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18806572     DOI: 10.1097/RLU.0b013e318184b9a0

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


× No keyword cloud information.
  5 in total

Review 1.  Current status of transarterial radioembolization.

Authors:  Andreas H Mahnken
Journal:  World J Radiol       Date:  2016-05-28

2.  Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potential.

Authors:  Linda M Pak; Nancy E Kemeny; Marinela Capanu; Joanne F Chou; Taryn Boucher; Andrea Cercek; Vinod P Balachandran; T Peter Kingham; Peter J Allen; Ronald P DeMatteo; William R Jarnagin; Michael I D'Angelica
Journal:  J Surg Oncol       Date:  2017-11-22       Impact factor: 3.454

3.  Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases.

Authors:  M Cosimelli; R Golfieri; P P Cagol; L Carpanese; R Sciuto; C L Maini; R Mancini; I Sperduti; G Pizzi; M G Diodoro; M Perrone; E Giampalma; B Angelelli; F Fiore; S Lastoria; S Bacchetti; D Gasperini; O Geatti; F Izzo
Journal:  Br J Cancer       Date:  2010-07-13       Impact factor: 7.640

Review 4.  Liver metastases from colorectal cancer: radioembolization with systemic therapy.

Authors:  Nils H Nicolay; David P Berry; Ricky A Sharma
Journal:  Nat Rev Clin Oncol       Date:  2009-11-03       Impact factor: 66.675

5.  Anatomical basis and histopathological changes resulting from selective internal radiotherapy for liver metastases.

Authors:  Lai Mun Wang; Anant R Jani; Esme J Hill; Ricky A Sharma
Journal:  J Clin Pathol       Date:  2012-11-16       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.